These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 20113912

  • 1. Exercise-uncovered pulmonary arterial hypertension and pharmacologic therapy: Clinical benefits.
    Park MH, Ramani GV, Kop WJ, Uber PA, Mehra MR.
    J Heart Lung Transplant; 2010 Feb; 29(2):228-9. PubMed ID: 20113912
    [No Abstract] [Full Text] [Related]

  • 2. Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension.
    Lewis GD, Shah R, Shahzad K, Camuso JM, Pappagianopoulos PP, Hung J, Tawakol A, Gerszten RE, Systrom DM, Bloch KD, Semigran MJ.
    Circulation; 2007 Oct 02; 116(14):1555-62. PubMed ID: 17785618
    [Abstract] [Full Text] [Related]

  • 3. [Importance of exercise test during heart catheterization for silicoses with beginning arterial pulmonary hypertension].
    Krause M, Harzbecker K, Mahrlein W.
    Dtsch Gesundheitsw; 1972 Mar 16; 27(11):521-3. PubMed ID: 5033836
    [No Abstract] [Full Text] [Related]

  • 4. Sildenafil therapy in secondary pulmonary hypertension: Is there benefit in prolonged use?
    Chapman TH, Wilde M, Sheth A, Madden BP.
    Vascul Pharmacol; 2009 Mar 16; 51(2-3):90-5. PubMed ID: 19386283
    [Abstract] [Full Text] [Related]

  • 5. Sildenafil therapy for pulmonary arterial hypertension associated with atrial septal defects.
    Lim ZS, Salmon AP, Vettukattil JJ, Veldtman GR.
    Int J Cardiol; 2007 May 31; 118(2):178-82. PubMed ID: 17027100
    [Abstract] [Full Text] [Related]

  • 6. Cardiopulmonary exercise test characteristics in patients with chronic obstructive pulmonary disease and associated pulmonary hypertension.
    Holverda S, Bogaard HJ, Groepenhoff H, Postmus PE, Boonstra A, Vonk-Noordegraaf A.
    Respiration; 2008 May 31; 76(2):160-7. PubMed ID: 17960052
    [Abstract] [Full Text] [Related]

  • 7. Does Sildenafil produce a sustained benefit in patients with pulmonary hypertension associated with parenchymal lung and cardiac disease?
    Madden BP, Sheth A, Wilde M, Ong YE.
    Vascul Pharmacol; 2007 May 31; 47(2-3):184-8. PubMed ID: 17627899
    [Abstract] [Full Text] [Related]

  • 8. [Pulmonary arterial hypertension in the elderly subject].
    Frachon I, Barnier A, Jobic Y, Gut-Gobert C, Etienne Y, Crutu A, Mialon P, Pasquier E, Nowak E, Mejri M, Couturaud F, Leroyer C, le groupe HTAP de Bretagne Occidentale.
    Rev Mal Respir; 2010 May 31; 27(1):30-6. PubMed ID: 20146949
    [Abstract] [Full Text] [Related]

  • 9. Pulmonary vascular disease in adults with congenital heart disease.
    Diller GP, Gatzoulis MA.
    Circulation; 2007 Feb 27; 115(8):1039-50. PubMed ID: 17325254
    [Abstract] [Full Text] [Related]

  • 10. [The pulmonary artery hypertension in patients with sarcoidosis (author's transl)].
    Rizzato G, Bertoli L, Merlini R, Tansini G, Scoccia S, Mantero O, Conti F.
    G Ital Cardiol; 1980 Feb 27; 10(3):309-15. PubMed ID: 7372047
    [Abstract] [Full Text] [Related]

  • 11. Role of oral sildenafil in severe pulmonary arterial hypertension: clinical efficacy and dose response relationship.
    Garg N, Sharma MK, Sinha N.
    Int J Cardiol; 2007 Sep 03; 120(3):306-13. PubMed ID: 17174417
    [Abstract] [Full Text] [Related]

  • 12. Pulmonary arterial hypertension and women.
    De Marco T.
    Cardiol Rev; 2006 Sep 03; 14(6):312-8. PubMed ID: 17053380
    [Abstract] [Full Text] [Related]

  • 13. [One-year controlled therapy with doxazosin in patients with pulmonary hypertension due to chronic obstructive pulmonary disease].
    Ludwik B, Lewczuk J, Piszko P, Nowak M, Wrabec K.
    Pol Merkur Lekarski; 2006 May 03; 20(119):527-30. PubMed ID: 16875154
    [Abstract] [Full Text] [Related]

  • 14. [Favorable response of pulmonary hypertension in patients with chronic obstructive airway disease treated with diltiazem].
    Gassner A.
    Schweiz Med Wochenschr; 1984 Mar 10; 114(10):332-7. PubMed ID: 6710104
    [Abstract] [Full Text] [Related]

  • 15. Primary pulmonary hypertension.
    Kuzman WJ.
    Med Times; 1970 Mar 10; 98(3):151-62. PubMed ID: 5416069
    [No Abstract] [Full Text] [Related]

  • 16. [Patent ductus arteriosus with pulmonary hypertension].
    Lavadenz R, Palmero E, Loma F, Carreon R.
    Arq Bras Cardiol; 1986 Nov 10; 47(5):323-7. PubMed ID: 3662871
    [No Abstract] [Full Text] [Related]

  • 17. Pharmacologic treatment of primary and secondary pulmonary hypertension.
    Brown G.
    Pharmacotherapy; 1991 Nov 10; 11(2):137-56. PubMed ID: 2052469
    [Abstract] [Full Text] [Related]

  • 18. ["Essential" or "thromboembolic" pulmonary hypertension. Clinical study of 5 cases].
    Krähenbühl B, Laperrouza C, Moret P.
    Schweiz Med Wochenschr; 1968 Aug 31; 98(35):1311-20. PubMed ID: 5682108
    [No Abstract] [Full Text] [Related]

  • 19. Postpartum pulmonary hypertension.
    Olley PM, Whitaker W.
    Obstet Gynecol; 1967 Mar 31; 29(3):369-77. PubMed ID: 6019086
    [No Abstract] [Full Text] [Related]

  • 20. [Efficacy of oral sildenafil as rescue therapy in patients with severe pulmonary arterial hypertension chronically treated with prostacyclin. Long-term results].
    Jiménez López-Guarch C, Escribano Subias P, Tello de Meneses R, Delgado Jiménez JF, Sadia Pérez D, Velázquez Martín MT, Gómez Sánchez MA, Sáenz de la Calzada C.
    Rev Esp Cardiol; 2004 Oct 31; 57(10):946-51. PubMed ID: 15469792
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.